T32 Trainees

University of Florida PhD students can apply to the T1D T32 by contacting Dr. Benjamin Keselowsky for application materials. The T32 Executive Committee will evaluate each applicant for academic standing and commitment to T1D research. Selected trainees will be appointed to the T32 beginning in August for a period of up to four years (contingent on satisfactory progress). Applicants must be US Citizens or permanent residents.

Current Trainees

Biomedical engineering

Alexander Kwiatkowski

Alexander studies tolerogenic dual microparticle systems for treatment of multiple sclerosis, under the mentorship of Dr. Benjamin Keselowsky.

Alexander Kwiatkowski

immunology & Microbiology

Leeana Peters

Leena utilizes single cell RNA-sequencing to perform immune profiling of NOD-CD226KO & human nPOD donor tissue, under the mentorship of Dr. Todd Brusko.

Leeana Peters

Biomedical engineering

Matthew Becker

Matthew researches tolerogenic exosomes as a therapeutic for treating T1D, under the mentorship of Dr. Edward Phelps. He recently won an F Award from the NIH!

Matthew Becker

immunology & Microbiology

Mollie Huber

Mollie investigates T1D pathogenesis with the live pancreas tissue slice platform, under the mentorship of Dr. Mark Atkinson.

Mollie Huber

biomedical engineering

Magdalena Samojlik

Magdalena engineers a dynamic three-dimensional in vitro platform for the investigation of human T1D immunopathogenesis

Magdalena Samojlik

T1D T32 Fellows receive a biweekly stipend, set annually by the NIH, that coincides with UF’s payroll schedule. T32 Fellows also receive $1,000 annually for travel and professional development activities. As part of the T1D T32, Fellows must participate in the Immunology Journal Club, the Diabetes Data Club, T1D-relevant seminars at the Genetics Institute, and the Biomedical Engineering Seminar Series.

Former Trainees

Trainee

Name and Degree

Research

Position

Employer

Joshua StewartJoshua Stewart, PhDA dual-sized microparticle system for inducing immune tolerance in autoimmunityConsultantCharles River Associates
Melanie ShapiroMelanie Shapiro, PhDInsulin-like growth factors as biomarkers with immunological impacts on the development of T1DPostdoc Assoc
University of Florida
Andrea LinAndrea Lin, PhDImmune changes with ATG+GCSF therapy and Its impacts on C-peptide preservation in T1DMedical Science LiaisonEMD Serono, Inc.
Nicholas AbuidNicholas Abuid, PhDEngineering cerium oxide nanoparticle coatings for antioxidant/anti-inflammatory protection of biomaterials and tissue graftsPostdoc AssocUniversity of Florida
Lucas ArmitageLucas Armitage, PhDPTPN22 regulates induced MHC-II expression in macrophagesPostdoc AssocUniversity of Colorado, Denver
Elliott DirrElliott Dirr, PhDTreatment of cardiometabolic dysfunction using targeted parasympathetic neuromodulationPostdoc AssocUniversity of Toledo